Prognostic biomarkers provide essential information about a patient’s overall outcome. However, existing biomarkers are limited in terms of either sample collection, such as requiring tissue specimens, or the process, such as prolonged time for analysis. | Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer A retrospective study